Mr. Chair, I will start with brief remarks and then go into questions for the purposes of your timing.
The COVID pandemic has been the greatest crisis in the modern history of our country. It has been a difficult year for Canada, for Canadian families, seniors, small businesses, front-line nurses, PSWs and doctors. Our country has pivoted in remarkable ways.
I want to thank those on our front lines who have been a part of the national response to COVID-19.
The questions we will have for the minister are based on Canada needing to do better. The very hybrid nature of Parliament itself is a result. People are working from home. We have a hybrid structure. The minister will be on a screen today as opposed to in the House where she was earlier today. That is a sign of the hybrid nature of how things are changing.
After months of lockdown, of uncertainty, of businesses failing, of people declaring bankruptcy and of people losing a loved one, a vaccine on the eve of Christmas was the hope for which our country was looking. That hope and that desire for Canada to do well, to recover and to help our people will underline my questions here tonight.
When was the minister first informed, or her office, by company representatives, telling them that the Pfizer vaccine would require specific logistics of a pharmaceutical-grade freezer and cold logistics chain?